• 1
    World Health Organization International Collaborative Study of Hypertensive Disorders of Pregnancy. Geographic variation in the incidence of hypertension in pregnancy. Am J Obstet Gynecol 1988;158:803.
  • 2
    Khan KS, Wojdyla D, Say L, Gülmezoglu AM, Van Look PFA. WHO analysis of causes of maternal death: a systematic review. Lancet 2006;367:106674.
  • 3
    Department of Health, Welsh Office, Scottish Office Department of Health, Department of Health and Social Services NI. Why Mothers Die: Report on Confidential Enquiries into Maternal Deaths in the United Kingdom, 1994–1996. London: TSO, 1998.
  • 4
    Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 1992;99:54753.
  • 5
    Department of Health. Confidential Enquiry into Stillbirths and Deaths in Infancy. London: Department of Health, 1996.
  • 6
    Wilson BJ, Watson MS, Prescott GJ, Sunderland S, Campbell DM, Hannaford P, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003;326:8459.
  • 7
    Irgens H, Reisaeter L, Irgens L, Lie R. Long term mortality of mothers and fathers after pre-eclampsia: population based cohort study. BMJ 2001; 323:121317.
  • 8
    Magpie Trial Collaborative Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 2002;359:187790.
  • 9
    Duley L, Gulmezoglu A, Henderson-Smart D. Magnesium sulphate and other anticonvulsants for women with pre-eclampsia. Cochrane Database Syst Rev 2003. Art. No.: CD000025. [DOI:10.1002/14651858].CD000025.
  • 10
    Nelson K, Grether J. Can magnesium sulfate reduce the risk of cerebral palsy in very low birthweight infants? Pediatrics 1995;95:2639.
  • 11
    Schendel D, Berg C, Yeargin-Allsopp M, Boyle C, Decoufle P. Prenatal magnesium sulfate exposure and the risk for cerebral palsy or mental retardation among very low-birth-weight children aged 3 to 5 years. JAMA 1996;276:180510.
  • 12
    Magpie Trial Follow Up Study Collaborative Group. The Magpie Trial: a randomized trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG DOI: 10.1111/j.1471-0528.2006.01165.x.
  • 13
    Magpie Trial Follow Up Study Management Group. The Magpie Trial Follow Up Study: outcome after discharge from hospital for women and children recruited to a trial comparing magnesium sulphate with placebo for pre-eclampsia [ISRCTN86938761]. BMC Pregnancy Childbirth 2004;4.
  • 14
    Farrell B, Duley L. Doing the undoable: Magpie Trial longterm followup. Lancet (in press).
  • 15
    WHO. Perinatal Mortality: A Listing of Available Information. WHO/FRH/MSM/96, 2nd edn. Geneva, Switzerland: WHO, 1996.
  • 16
    O‘Hara M, Swain AM. Rates and risk of postpartum depression—a meta-analysis. Int Rev Psychiatry 1996;8:3754.
  • 17
    Tomlinson M, Cooper P, Stein A, Swartz L, Molteno C. Post-partum depression and infant growth in a South African peri-urban settlement. Child Care Health Dev 2006;32:816.
  • 18
    Patel V, Rahman A, Jacob KS, Hughes M. Effect of maternal mental health on infant growth in low income countries: new evidence from South Asia. BMJ 2004;328:8203.
  • 19
    Murray L, Woolgar M, Murray J, Cooper P. Self-exclusion from health care in women at high risk for postpartum depression. J Public Health Med 2003;25:1317.